BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11197301)

  • 1. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression.
    Tang J; Rivers C; Karita E; Costello C; Allen S; Fultz PN; Schoenbaum EE; Kaslow RA
    Genes Immun; 1999 Sep; 1(1):20-7. PubMed ID: 11197301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
    Knudsen TB; Kristiansen TB; Katzenstein TL; Eugen-Olsen J;
    J Med Virol; 2001 Nov; 65(3):441-4. PubMed ID: 11596075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
    Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
    J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
    J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polymorphisms of chemokine receptor alleles influencing genetic susceptibility to HIV-1 infection in Mongolia population in China].
    Du Q; Wang F; Hong W; Liu M; Jin L; Shi H; Lei Z; E E
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):413-6. PubMed ID: 11860823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression.
    Easterbrook PJ; Rostron T; Ives N; Troop M; Gazzard BG; Rowland-Jones SL
    J Infect Dis; 1999 Oct; 180(4):1096-105. PubMed ID: 10479136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability--a study of 4 individuals infected with closely related HIV-1 strains.
    Chalmet K; Van Wanzeele F; Demecheleer E; Dauwe K; Pelgrom J; Van Der Gucht B; Vogelaers D; Plum J; Stuyver L; Vandekerckhove L; Verhofstede C
    Virology; 2008 Sep; 379(2):213-22. PubMed ID: 18692212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
    Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
    HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analyses of cis-acting sequences controlling expression of human immunodeficiency virus type 1 coreceptor-CCR5 gene in rabbits and CXCR4 gene in monkeys.
    Shanmugasundaram GK; Sundaresan G; Shoeb F; Arumugam N; Kumaravelu J; Unwalla H; Chakraborti S; Banerjea AC
    J Hum Virol; 2001; 4(4):188-94. PubMed ID: 11694846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.
    Ometto L; Bertorelle R; Mainardi M; Zanchetta M; Tognazzo S; Rampon O; Ruga E; Chieco-Bianchi L; De Rossi A
    J Infect Dis; 2001 Mar; 183(5):814-8. PubMed ID: 11181160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
    Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y
    Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
    Lathey JL; Tierney C; Chang SY; D'Aquila RT; Bettendorf DM; Alexander HC; Santini CD; Hughes AM; Barroga CF; Spector SA; Landes JE; Hammer SM; Katzenstein DA
    J Infect Dis; 2001 Dec; 184(11):1402-11. PubMed ID: 11709782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common promoter deletion is associated with 3.9-fold differential transcription of ovine CCR5 and reduced proviral level of ovine progressive pneumonia virus.
    White SN; Mousel MR; Reynolds JO; Lewis GS; Herrmann-Hoesing LM
    Anim Genet; 2009 Oct; 40(5):583-9. PubMed ID: 19397512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.
    Liu H; Hwangbo Y; Holte S; Lee J; Wang C; Kaupp N; Zhu H; Celum C; Corey L; McElrath MJ; Zhu T
    J Infect Dis; 2004 Sep; 190(6):1055-8. PubMed ID: 15319853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.
    Su B; Sun G; Lu D; Xiao J; Hu F; Chakraborty R; Deka R; Jin L
    Eur J Hum Genet; 2000 Dec; 8(12):975-9. PubMed ID: 11175286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of new mutant sites and 894C deletion variant genotyping of HIV-1 coreceptor CCR5 in indigenous Chinese populations].
    Liu M; Wang F; Hong W; Wang B; Jin L; Lei Z; Hou J
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1468-72. PubMed ID: 12509908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
    Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
    Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression.
    Paxton WA; Kang S
    Semin Immunol; 1998 Jun; 10(3):187-94. PubMed ID: 9653045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.